XML 33 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Tables)
 9 Months Ended
Oct. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Compensation Costs
The compensation costs that have been charged against income were as follows (in thousands):

13-Weeks Ended39-Weeks Ended
October 31,
2020		November 2,
2019		October 31,
2020		November 2,
2019
Stock-based compensation expense by type:
Stock options
$— $— $90 $92 
Restricted stock units968 859 2,615 1,576 
Employee stock purchases
23 22 93 73 
Director deferred compensation23 24 71 70 
  Total stock-based compensation expense1,014 905 2,869 1,811 
Income tax benefit recognized244 295 672 428 
  Stock-based compensation expense, net of income tax$770 $610 $2,197 $1,383 
Schedule of Equity Awards Granted
We have granted the following equity awards:

13-Weeks Ended39-Weeks Ended
October 31,
2020		November 2,
2019		October 31,
2020		November 2,
2019
Stock options
— — 27,000 16,798 
Restricted stock unit awards
— 6,934 337,749 229,528 
Performance-based restricted stock unit awards
— — — 34,300 
Deferred stock units
597 1,023 3,860 3,338 
Schedule of Shares Purchased
The number of shares purchased, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:
13-Weeks Ended39-Weeks Ended
October 31,
2020		November 2,
2019		October 31,
2020		November 2,
2019
Shares purchased4,605 5,652 33,506 21,205 
Average price per share$17.66 $15.73 $10.21 $13.99 
Weighted-average fair value at grant date$4.99 $4.16 $3.71 $3.96